Girish Dhall MD

Pediatric Hematology & Oncology•Birmingham, AL

Pediatric Neuro-Oncology

Professor, Pediatrics, University of Alabama at Birmingham

Request Appointment

1600 7th Avenue SouthBirmingham, AL 35233
Book by Phone+1(659) 256-3116

Education & Training

NYU Grossman School of MedicineFellowship, Pediatric Hematology/Oncology, 2000 - 2003
Westchester Medical CenterResidency, Pediatrics, 1997 - 2000
Grant Medical CollegeClass of 1994

Certifications & Licensure

AL State Medical License 2019 - 2025
CA State Medical License 2005 - 2019
FL State Medical License 2013 - 2015
NJ State Medical License 2003 - 2007
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors Start of enrollment: 2004 Mar 01
Unknown status
Phase 3
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Start of enrollment: 2009 Feb 25
Completed
Phase 1
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Start of enrollment: 2010 Jul 07
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) Start of enrollment: 2010 Aug 01
Completed
Phase 2
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas Start of enrollment: 2012 Feb 01
Completed
Phase 1, Phase 2
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
Completed
Phase 1
Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery Start of enrollment: 2014 Apr 01
Terminated
Phase 2
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors Start of enrollment: 2013 Aug 01
Completed
Phase 1
Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma Start of enrollment: 2017 Apr 04
Terminated
Early Phase 1
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Start of enrollment: 2015 Jul 14
Completed
Phase 1
Panobinostat in Treating Younger Patients With Progressive Diffuse Intrinsic Pontine Glioma Start of enrollment: 2016 Apr 01
Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG Start of enrollment: 2017 Apr 04
ACTIVE_NOT_RECRUITING
NA
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults Start of enrollment: 2020 Oct 02
RECRUITING
PHASE1
Roles: Contact
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) Start of enrollment: 2020 Dec 09
RECRUITING
PHASE1
Roles: Contact
Combination Therapy for the Treatment of Diffuse Midline Gliomas Start of enrollment: 2021 Oct 20
RECRUITING
PHASE2
Roles: Contact, Principal Investigator
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
ACTIVE_NOT_RECRUITING
PHASE4
Roles: Contact, Study Chair
Join now to see all

Publications & Presentations

PubMed

Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions.
Mary Jane Lim-Fat, Julie Bennett, Quinn Ostrom, Mehdi Touat, Enrico Franceschi
Neuro-Oncology. 2025-01-12
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Youn...
Gemma Bryan, Louise Guolla, Gabriela Inés Villanueva, Sarah Cohen-Gogo, Alejandra Casanovas
Pediatric Blood & Cancer. 2025-01-01
Intracranial germ cell tumors: advancement in genomic diagnostics and the need for novel therapeutics.
Kee Kiat Yeo, Joanna Gell, Girish Dhall, Ching Lau
Frontiers in Oncology. 2025-01-01

Press Mentions

UAB’s Coronavirus Testing Site Receives $200,000 from HyundaiApril 4th, 2020
Siblings Diagnosed 13 Days Apart with Brain Cancer Finish TreatmentAugust 2nd, 2019
Career Briefs: Girish Dhall, M.D., Has Been Named as Division Director for the Hematology-Oncology and Blood Marrow Transplantation ProgramJanuary 26th, 2019

Girish Dhall MD

Overview of Dr. Dhall

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.